Khan M, Shakya M, Verma C
Mol Divers. 2025; .
PMID: 40057939
DOI: 10.1007/s11030-025-11148-z.
Lisac L, Raccagni A, Lolatto R, Passini F, Maci C, Bruzzesi E
Viruses. 2024; 16(11).
PMID: 39599903
PMC: 11599056.
DOI: 10.3390/v16111789.
He X, Shu H, Xu T, Yu M, Li H, Hu Y
Metabolites. 2024; 14(11).
PMID: 39590852
PMC: 11596958.
DOI: 10.3390/metabo14110616.
Lorkiewicz P, Waszkiewicz N
Front Cell Infect Microbiol. 2024; 14:1423739.
PMID: 39206043
PMC: 11349683.
DOI: 10.3389/fcimb.2024.1423739.
Hao C, Xu Z, Xu C, Yao R
Front Cell Infect Microbiol. 2024; 13:1302096.
PMID: 38259968
PMC: 10800978.
DOI: 10.3389/fcimb.2023.1302096.
The Interplay of Genital Herpes with Cellular Processes: A Pathogenesis and Therapeutic Perspective.
Borase H, Shukla D
Viruses. 2023; 15(11).
PMID: 38005873
PMC: 10675801.
DOI: 10.3390/v15112195.
In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
Wei A, Yin D, Zhai Z, Ling S, Le H, Tian L
Mol Ther. 2023; 31(11):3163-3175.
PMID: 37658603
PMC: 10638052.
DOI: 10.1016/j.ymthe.2023.08.021.
Antiviral Potential of the Genus : An updated review on their effects and underlying mechanism of action.
Zhang Y, Zhong X, Xi Z, Li Y, Xu H
J Ginseng Res. 2023; 47(2):183-192.
PMID: 36926608
PMC: 10014226.
DOI: 10.1016/j.jgr.2022.11.003.
Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus.
Malik S, Sah R, Ahsan O, Muhammad K, Waheed Y
Vaccines (Basel). 2023; 11(2).
PMID: 36851203
PMC: 9959597.
DOI: 10.3390/vaccines11020325.
PKHB1 peptide induces antiviral effects through induction of immunogenic cell death in herpes simplex keratitis.
He Y, Wang C, Liang Q, Guo R, Jiang J, Shen W
Front Pharmacol. 2022; 13:1048978.
PMID: 36532743
PMC: 9751201.
DOI: 10.3389/fphar.2022.1048978.
Superior antiviral activity of IFNβ in genital HSV-1 infection.
Schmitz Y, Schwerdtfeger M, Westmeier J, Littwitz-Salomon E, Alt M, Brochhagen L
Front Cell Infect Microbiol. 2022; 12:949036.
PMID: 36325470
PMC: 9618724.
DOI: 10.3389/fcimb.2022.949036.
The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases.
Ciaston I, Dobosz E, Potempa J, Koziel J
Mol Aspects Med. 2022; 88:101143.
PMID: 36152458
PMC: 9924004.
DOI: 10.1016/j.mam.2022.101143.
Isatin derivatives as broad-spectrum antiviral agents: the current landscape.
Elsaman T, Mohamed M, Eltayib E, Abdel-Aziz H, Abdalla A, Munir M
Med Chem Res. 2022; 31(2):244-273.
PMID: 35039740
PMC: 8754539.
DOI: 10.1007/s00044-021-02832-4.
Developments in Vaccination for Herpes Simplex Virus.
Krishnan R, Stuart P
Front Microbiol. 2021; 12:798927.
PMID: 34950127
PMC: 8691362.
DOI: 10.3389/fmicb.2021.798927.
Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques.
Nath P, Kabir M, Doust S, Ray A
Infect Dis Rep. 2021; 13(2):518-539.
PMID: 34199547
PMC: 8293188.
DOI: 10.3390/idr13020049.
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.
Heidbuechel J, Engeland C
J Hematol Oncol. 2021; 14(1):63.
PMID: 33863363
PMC: 8052795.
DOI: 10.1186/s13045-021-01075-5.
Antiviral potential of natural products from marine microbes.
Yi M, Lin S, Zhang B, Jin H, Ding L
Eur J Med Chem. 2020; 207:112790.
PMID: 32937282
PMC: 7457942.
DOI: 10.1016/j.ejmech.2020.112790.
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1.
Silke Heilingloh C, Lull C, Kleiser E, Alt M, Schipper L, Witzke O
Vaccines (Basel). 2020; 8(3).
PMID: 32867086
PMC: 7563860.
DOI: 10.3390/vaccines8030478.
A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect.
Xu X, Feng X, Wang L, Yi T, Zheng L, Jiang G
PLoS Pathog. 2020; 16(8):e1008703.
PMID: 32776994
PMC: 7440667.
DOI: 10.1371/journal.ppat.1008703.
Immune Response to Herpes Simplex Virus Infection and Vaccine Development.
Ike A, Onu C, Ononugbo C, Reward E, Muo S
Vaccines (Basel). 2020; 8(2).
PMID: 32545507
PMC: 7350219.
DOI: 10.3390/vaccines8020302.